20004-92-6Relevant academic research and scientific papers
Antihypertensive thiocarbamoylascetonitrile compounds
-
, (2008/06/13)
Disclosed are antihypertensive pharmaceutical compositions and compounds which include the thiocarbamoylacetonitrile having the formula: STR1 wherein: R1 is selected from the group consisting of hydrogen, a C1 to C6 alkyl, a C3 to C6 cycloalkyl or --(CH2)n --A (where A is selected from the group consisting of a C6 to C12 aryl, a 5- or 6-membered heterocyclic group or a fused heterocyclic group constituted by 9 or 10 atoms, each of which may be substituted by at least one substitute group selected from a C1 to C6 alkyl and a halogen and n is 0 or an integer of 1 to 6), R2 represents a C1 to C10 alkyl, and Ar represents an aryl, a 5- or 6-membered heterocyclic group or a fused heterocyclic group, each of which may be substituted by at least one substituent group selected from the group consisting of a C1 to C6 alkyl, a C1 to C6 alkoxy, a C2 to C7 alkylcarbonyl, a C7 to C6 dialkylamino, amino, formylamino, a C2 to C7 alkylcarbonylamino, a halogen, cyano, nitro, hydroxyl, a C1 to C6 alkylthio, a C6 to C12 arylsulfinyl, a C1 to C6 alkylsulfinyl, a C6 to C12 alkylsulfonyl, a C6 to C12 arylsulfonyl, aminosulfonyl, a C1 to C6 alkylaminosulfonyl, a C2 to C6 dialkylaminosulfonyl, trifluoromethyl and imidazolyl.
